Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.

CONCLUSION: Our results suggest that patients who had pretransplant hepatic malignancy be followed up more strictly because they have a potential risk of primary hepatic malignancy recurrence as well as a higher risk of extrahepatic DNM than patients without pretransplant hepatic malignancy. PMID: 32193900 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32193900?dopt=Abstract

Source: J Korean Med Sci - March 21, 2020 Category: General Medicine Authors: Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Yoon YI, Cho HD, Kwon JH, Chung YK, Kang SH, Choi JU, Jung IJ, Lee SG Tags: J Korean Med Sci Source Type: research